These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 20672144)

  • 21. Differences in the efficacy and safety among inhaled corticosteroids (ICS)/long-acting beta2-agonists (LABA) combinations in the treatment of chronic obstructive pulmonary disease (COPD): Role of ICS.
    Latorre M; Novelli F; Vagaggini B; Braido F; Papi A; Sanduzzi A; Santus P; Scichilone N; Paggiaro P
    Pulm Pharmacol Ther; 2015 Feb; 30():44-50. PubMed ID: 25445928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma.
    Chapman KR; Patel P; D'Urzo AD; Alexander M; Mehra S; Oedekoven C; Engelstätter R; Boulet LP
    Allergy; 2005 Mar; 60(3):330-7. PubMed ID: 15679718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K; Kanniess F; Biberger C; Nave R; Magnussen H
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
    Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
    Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of inhaled ciclesonide and fluticasone propionate on cortisol secretion and airway responsiveness to adenosine 5'monophosphate in asthmatic patients.
    Derom E; Van De Velde V; Marissens S; Engelstätter R; Vincken W; Pauwels R
    Pulm Pharmacol Ther; 2005; 18(5):328-36. PubMed ID: 15939311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ciclesonide: a novel inhaled corticosteroid for asthma.
    Christie P
    Drugs Today (Barc); 2004 Jul; 40(7):569-76. PubMed ID: 15510231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 24-week comparison of low-dose ciclesonide and fluticasone propionate in mild to moderate asthma.
    Dahl R; Engelstätter R; Trebas-Pietraś E; Kuna P
    Respir Med; 2010 Aug; 104(8):1121-30. PubMed ID: 20430601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhaled corticosteroids for asthma: are they all the same?
    Baptist AP; Reddy RC
    J Clin Pharm Ther; 2009 Feb; 34(1):1-12. PubMed ID: 19125898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
    Lipworth BJ
    Arch Intern Med; 1999 May; 159(9):941-55. PubMed ID: 10326936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
    Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
    Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of the newer inhaled corticosteroids in childhood asthma.
    Randell TL; Donaghue KC; Ambler GR; Cowell CT; Fitzgerald DA; van Asperen PP
    Paediatr Drugs; 2003; 5(7):481-504. PubMed ID: 12837120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ciclesonide, a novel inhaled steroid, does not affect hypothalamic-pituitary-adrenal axis function in patients with moderate-to-severe persistent asthma.
    Szefler S; Rohatagi S; Williams J; Lloyd M; Kundu S; Banerji D
    Chest; 2005 Sep; 128(3):1104-14. PubMed ID: 16162694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Low-Dose Ciclesonide and Fluticasone Propionate for Mild to Moderate Persistent Asthma.
    Jamaati H; Malekmohammad M; Fahimi F; Najafi A; Hashemian SM
    Tanaffos; 2015; 14(1):1-9. PubMed ID: 26221146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ciclesonide: a closer look at its systemic and oropharyngeal safety profile.
    Berger WE
    Curr Drug Saf; 2006 Aug; 1(3):265-70. PubMed ID: 18690937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
    van der Molen T; Postma DS; Martin RJ; Herings RM; Overbeek JA; Thomas V; Miglio C; Dekhuijzen R; Roche N; Guilbert T; Israel E; van Aalderen W; Hillyer EV; van Rysewyk S; Price DB
    BMC Pulm Med; 2016 May; 16(1):80. PubMed ID: 27184175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal suppression by inhaled corticosteroids in patients with asthma: A systematic review and quantitative analysis.
    Kowalski ML; Wojciechowski P; Dziewonska M; Rys P
    Allergy Asthma Proc; 2016; 37(1):9-17. PubMed ID: 26831841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effectiveness in ciclesonide and fluticasone propionate on small airway function in mild asthma.
    Hoshino M
    Allergol Int; 2010 Mar; 59(1):59-66. PubMed ID: 20035146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Particle size matters: diagnostics and treatment of small airways involvement in asthma.
    Cohen J; Postma DS; Douma WR; Vonk JM; De Boer AH; ten Hacken NH
    Eur Respir J; 2011 Mar; 37(3):532-40. PubMed ID: 20595155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized study comparing ciclesonide and fluticasone propionate in patients with moderate persistent asthma.
    Boulet LP; Bateman ED; Voves R; Müller T; Wolf S; Engelstätter R
    Respir Med; 2007 Aug; 101(8):1677-86. PubMed ID: 17448650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.